Organized by the Global Initiative for Asthma (GINA), World Asthma Day is an annual awareness day aimed at raising awareness of asthma and improving healthcare, with this year’s theme focusing on ‘Asthma care for All’1. Thanks to over 15 years of experience in FeNO monitoring, Bedfont® Scientific Ltd has developed... read more →

World Lung Day is an annual occurrence on the 25th September, which aims to promote better lung health. Poor lung health can lead to many conditions, including asthma, a chronic condition of the lungs, causing difficulty in breathing, that affects over 12% of the UK population1. But thanks to technologies... read more →

When a person’s airways are not working correctly, the resulting difficulty in breathing can be detrimental to everyday activities and lead to more serious health risks. According to the World Health Organization, asthma – a chronic condition where a person’s airways are narrow and inflamed, making airflow difficult – is... read more →

When a person’s airways are not working correctly, the resulting difficulty in breathing can be detrimental to everyday activities and lead to more serious health risks. According to the World Health Organization, asthma – a chronic condition where a person’s airways are narrow and inflamed, making airflow difficult – is... read more →

UK, med-tech company, Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation. About the NObreath® FeNO Monitor The NObreath®, which conforms to ATS and ERS guidelines1, is a portable, non-invasive device for... read more →

NHS Organisations can apply for funding from the Pathway Transformation Fund (PTF) to obtain a NObreath® used for asthma diagnosis and management. The NObreath® FeNO monitor from Bedfont® Scientific Ltd. has been included on the Rapid Uptake Products (RUPs) scheme by the NHS Accelerated Access Collaborative (AAC). One of the... read more →

Funding Opportunities for NHS Organisations NHS Organisations can apply for funding from the Pathway Transformation Fund (PTF) to obtain a NObreath® used for asthma diagnosis and management. NObreath® FeNO Device: Part of the Rapid Uptake Products (RUPs) Scheme The NObreath® FeNO device from Bedfont® Scientific Ltd. has been included in... read more →

The Trouble with Diagnosing Asthma Approximately 339 million people across the globe suffer from asthma, and asthma-related deaths affect the lives of three families daily. Of these, up to two-thirds of deaths due to attacks are preventable. Inadequate treatment and poor management as well as issues with diagnosis contribute to... read more →

Bedfont announces launch of 2nd generation NObreath at ERS 2018, Paris Bedfont Scientific Ltd. launches their new FeNO monitor exclusively at the world’s largest European Respiratory Society Congress. Medical device manufacturer, Bedfont, specialising in breath analysis for 40+ years, have announced a new and improved 2nd generation NObreath. The monitor... read more →